Toxic aldehyde related diseases and treatment
US11007157B2 · kind B2 · utility
15Cited by
48References
41Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Jan 27, 2020 |
| Grant date | May 18, 2021 |
| Priority date | — |
| Expiry date | Jan 27, 2040 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC08K5/18
- WIPO fieldPharmaceuticals
- WIPO sectorChemistry
Abstract
The present invention provides for the treatment, prevention, and/or reduction of a risk of a disease, disorder, or condition in which aldehyde toxicity is implicated in the pathogenesis, including ocular disorders, skin disorders, conditions associated with injurious effects from blister agents, and autoimmune, inflammatory, neurological and cardiovascular diseases by the use of a primary amine to scavenge toxic aldehydes, such as MDA and HNE.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.